Reuters logo
BRIEF-TBG Diagnostics ‍Unit Will Form A 60/40 JV With Xiamen Haicang
December 3, 2017 / 11:19 PM / 14 days ago

BRIEF-TBG Diagnostics ‍Unit Will Form A 60/40 JV With Xiamen Haicang

Dec 4 (Reuters) - TBG Diagnostics Ltd:

* ‍UNIT TBG BIOTECHNOLOGY CORP. WILL FORM A 60/40 JOINT VENTURE WITH XIAMEN HAICANG BIOTECHNOLOGY DEVELOPMENT CO​

* ‍BOTH COMPANIES COMMITTED TO TOTAL CAPITAL OF 30 MILLION RMB FOR JV WITH TBG CONTRIBUTING 60% AND XIAMEN HAICANG 40%​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below